Cyfuse Biomedical K.K. (4892)
Market Open
7 Aug, 06:00
JPX JPX Primary ¥
531. 00
+11
+2.1154%
¥
5.42B Market Cap
- P/E Ratio
- Div Yield
23,600 Volume
- Eps
¥ 520
Previous Close Want to track 4892 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Cyfuse Biomedical K.K. (4892) Statistics
Valuation metrics
Market Cap 5.42B
Enterprise value 3.06B
Trailing P/E (ttm) -5.94
Forward P/E -
PEG ratio -0.62
Price/Sales (ttm) 22.78
Price/Book (mrq) 1.92
Enterprise Value/Revenue 13.02
Enterprise Value/EBITDA -3.98
Overview
Shares outstanding 9.61M
Float 6.67M
Shares short -
% Held by insiders 0.25%
% Held by institutions 0.03%
Average volume (10 days) 29.76K
Average volume (90 days) 40.59K
Price summary
52-Week low 487
52-Week high 764
Beta 1.47
50-Day moving average 530.11
200-Day moving average 603.9
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2025
Profitability
Profit margin -3.51%
Operating margin -3.42%
Operational effectiveness
Return on assets -0.2%
Return on equity -0.31%
Income Statement
Revenue (ttm) 230M
Revenue per share (ttm) 23.67
Quarterly revenue growth (yoy) 5.04%
Gross profit (ttm) 113M
EBITDA -792M
Net income to common (ttm) -763M
Diluted EPS (ttm) -83.02
Quarterly earnings growth (yoy) -0.35%
Balance Sheet
Total cash (mrq) 3.73B
Total cash per share (mrq) 355.52
Total debt (mrq) 1.31B
Total Debt/Equity (mrq) 0.45
Current ratio (mrq) 4.55%
Book value per share (mrq) 276.44
Cash Flow
Cash flow statement -534M
Levered free cash flow (LFCF) -483.5M
